According to Straits Research, the global Antihypertensive Drugs Market was valued at USD 22.60 billion in 2023 and is projected to grow from USD 23.61 billion in 2024 to USD 33.49 billion by 2032, expanding at a compound annual growth rate (CAGR) of 3.87% during the forecast period (2024–2032). This upward trajectory underscores the escalating demand for innovative hypertension therapies amid rising global health challenges.
Comments
0 comment